TNF-alpha immunosuppressive use and future malignancy risk.
Volume: 39, Issue: 15_suppl, Pages: 10558 - 10558
Published: May 20, 2021
Abstract
10558 Background: Tumor Necrosis Factor Alpha (TNF-a) inhibitors suppress the immune system in patients with systemic inflammatory conditions. Long term data assessing future cancer risk for these patients is not known. We assessed long term risk of malignancy in patients with Rheumatoid Arthritis [RA], Inflammatory Bowel Disease [IBD], Psoriasis [PS], and Ankylosing Spondylitis [AS], who were or were not exposed to a TNF-a inhibitor. Methods:...
Paper Details
Title
TNF-alpha immunosuppressive use and future malignancy risk.
Published Date
May 20, 2021
Journal
Volume
39
Issue
15_suppl
Pages
10558 - 10558
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History